Battelle Ventures, L.P., and its affiliate fund, Innovation Valley Partners (IVP), have a combined $255 million under management to create
Business Model:
Revenue: $10.6M
Employees: 2-10
Address: 100 Princeton South Corporate Ctr
City: Ewing
State: NJ
Zip: 08628
Country: US
Battelle Ventures, L.P., and its affiliate fund, Innovation Valley Partners (IVP), have a combined $255 million under management to create and accelerate the development of early-stage technology companies with breakthrough solutions to key market problems. The funds enjoy close relationships with the technology transfer offices of the National Laboratories that Battelle Memorial Institute (Battelle) manages or co-manages for the U.S. Department of Energy. They also have established similar associations with a number of university tech transfer and commercialization departments.
Contact Phone:
+16099211456
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2006 | RemoteReality | Series A | 7.3M |
11/2014 | Bionano Genomics | Series C | 0 |
10/2013 | Bionano Genomics | Series C | 0 |
8/2007 | Sypherlink | Series B | 0 |
6/2008 | NellOne Therapeutics | Venture Round | 0 |
1/2013 | Micro Interventional Devices | Series B | 0 |
3/2008 | Bionano Genomics | Series A | 5.1M |
8/2010 | GRIDSMART Technologies | Venture Round | 0 |
12/2007 | Hi-G-Tek | Venture Round | 5.5M |
7/2012 | Bionano Genomics | Series B | 0 |
4/2007 | Superprotonic | Series B | 16.2M |
12/2007 | CDI Bioscience | Venture Round | 3M |
12/2005 | Multispectral Imaging | Series B | 0 |
7/2006 | Rajant Corporation | Series B | 3.3M |
3/2011 | Bionano Genomics | Series B | 0 |
10/2007 | GRIDSMART Technologies | Series A | 3.8M |
10/2005 | SmartSynch | Series C | 12M |
12/2012 | Proterro | Series A | 3.5M |
4/2005 | Ventaira Pharmaceuticals | Series C | 0 |
5/2006 | BioVigilant Systems | Series A | 0 |
9/2006 | Hi-G-Tek | Venture Round | 10M |
1/2006 | ENDOVALVE | Series A | 2.5M |
7/2004 | SafeView | Series B | 16M |
7/2008 | RemoteReality | Venture Round | 600k |
9/2008 | Hepregen | Series A | 0 |
3/2010 | Nistica | Series C | 0 |
5/2007 | Metatomix | Series B | 0 |
5/2006 | Metatomix | Private Equity Round | 0 |
2/2011 | Nistica | Series D | 0 |
2/2008 | Nistica | Series B | 0 |
1/2010 | Hepregen | Grant | 0 |
7/2008 | NuPathe | Series B | 30M |
2/2007 | ENDOVALVE | Series B | 8M |
6/2005 | Sypherlink | Series A | 3.5M |
11/2014 | Bionano Genomics | Series C | 0 |
10/2013 | Bionano Genomics | Series C | 0 |
1/2013 | Micro Interventional Devices | Series B | 0 |
12/2012 | Proterro | Series A | 0 |
7/2012 | Bionano Genomics | Series B | 0 |
3/2011 | Bionano Genomics | Series B | 0 |
2/2011 | Nistica | Series D | 0 |
8/2010 | GRIDSMART Technologies | Venture Round | 0 |
3/2010 | Nistica | Series C | 0 |
1/2010 | Hepregen | Grant | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|